Cargando…

Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer

Patients with platinum-resistant ovarian cancer (PROC) have limited therapeutic options and poor survival. There is a need for the development of newer therapies. Sodium valproic acid (VPA) is a short-chain fatty acid histone deacetylase (HDAC) inhibitor with antitumor activity in preclinical models...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakka, Thejeswar, Goenka, Luxitaa, Dubashi, Biswajit, Kayal, Smita, Mathaiyan, Jayanthi, Barathi, Deepak, Krishnamoorthy, Narendran, Thumaty, Divya Bala, Dahagama, Sindhu, Ganesan, Prasanth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522437/ https://www.ncbi.nlm.nih.gov/pubmed/36175588 http://dx.doi.org/10.1007/s12032-022-01833-6

Ejemplares similares

The “collateral damage” of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer
por: Goenka, Luxitaa, et al.
Publicado: (2021)

Poster: ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study
por: Anandaradje, Annuja, et al.
Publicado: (2021)

ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study
por: Anandaradje, Annuja, et al.
Publicado: (2021)

Baricitinib: Two Birds with One Stone
por: Saj, Fen, et al.
Publicado: (2022)

Efficacy and safety of pomalidomide, bortezomib, and dexamethasone combination chemotherapy for newly diagnosed multiple myeloma: POMACE Phase II Study
por: Saj, Fen, et al.
Publicado: (2023)

P909: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE CHEMOTHERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: POMACE PHASE II STUDY
por: Saj, Fen, et al.
Publicado: (2023)

Cytotoxic chemotherapy is associated with decreased bone mineral density in postmenopausal women with early and locally advanced breast cancer
por: Nisha, Yadav, et al.
Publicado: (2023)

Challenges in the Management of Lung Cancer: Real-World Experience from a Tertiary Center in South India
por: Gopal, Vishnu, et al.
Publicado: (2021)

Authors’ reply
por: Mathaiyan, Jayanthi, et al.
Publicado: (2015)

Prescription errors in cancer chemotherapy: Omissions supersede potentially harmful errors
por: Mathaiyan, Jayanthi, et al.
Publicado: (2015)

Identification of Differentially Expressed miRNA by Next Generation Sequencing in Locally Advanced Breast Cancer Patients of South Indian Origin
por: Tripathi, Shyam Kumar, et al.
Publicado: (2022)

Level of Anxiety and Depression and Its Clinical and Sociodemographic Determinants among the Parents of Children with Cancer Undergoing Chemotherapy
por: Srivastava, Shivayan, et al.
Publicado: (2020)

Alirocumab in Post ACS Patients - Saving Lives at a Premium
por: George, Melvin, et al.
Publicado: (2022)

The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic  Nephropathy
por: Goenka, Luxitaa, et al.
Publicado: (2019)

First-Line Durvalumab Plus Platinum-Etoposide Versus Platinum-Etoposide for Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis
por: Zhang, Longfeng, et al.
Publicado: (2020)

Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial
por: Radhakrishnan, Venkatraman, et al.
Publicado: (2022)

Correction: Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial
por: Radhakrishnan, Venkatraman, et al.
Publicado: (2022)

Valproate: It's Effects on Hair
por: Kakunje, Anil, et al.
Publicado: (2018)

Assessment of Oral Anticancer Medication Adherence: A Survey from a Tertiary Cancer Center
por: Ramachandiran, Balaji, et al.
Publicado: (2021)

Plerixafor use in autologous hematopoietic stem cell mobilization: Experience from a single center in Southern India
por: Das, Soumya, et al.
Publicado: (2022)

Influence of DPYD*9A, DPYD*6 and GSTP1 ile105val Genetic Polymorphisms on Capecitabine and Oxaliplatin (CAPOX) Associated Toxicities in Colorectal Cancer (CRC) Patients
por: K, Ashok Varma, et al.
Publicado: (2019)

Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms
por: Lacombe, Caroline, et al.
Publicado: (2021)

The combination of etoposide and platinum for the treatment of thymic neuroendocrine neoplasms: A retrospective analysis
por: Guan, Yelan, et al.
Publicado: (2023)

The assessment of the quality of randomized controlled trials published in Indian medical journals
por: Goenka, Luxitaa, et al.
Publicado: (2019)

Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer
por: van der Burg, M E L, et al.
Publicado: (2002)

Anlotinib combined with etoposide for platinum-resistant recurrent ovarian cancer: A case report
por: Sun, Li, et al.
Publicado: (2020)

Wide Cost Variations Observed in Antibiotics and Analgesics Prescribed for Dental Care in India: A Price and Affordability Analysis
por: Gauthaman, Jeevitha, et al.
Publicado: (2022)

Refractory Choriocarcinoma: Complete Response With Oral Etoposide
por: Dhanushkodi, Manikandan, et al.
Publicado: (2016)

Late Effects of Breast Cancer Treatment and Outcome after Corrective Interventions
por: Pillai, Unni S, et al.
Publicado: (2019)

Monitoring Antibiotic Use in Public Health Care Facilities of South Indian Union Territory: A Step to Promote Rational Use of Antibiotics
por: Meena, Dinesh K, et al.
Publicado: (2021)

Cost Analysis of Different Antibiotic Brands Available in Indian Market with Reference to National List of Essential Medicines
por: Meena, Dinesh Kumar, et al.
Publicado: (2021)

L-Asparginase induced cortical venous thrombosis in a patient with acute leukemia
por: Dubashi, Biswajit, et al.
Publicado: (2012)

Docetaxel-induced hand foot syndrome: “No dose is a safe dose”
por: Jain, Ankit, et al.
Publicado: (2012)

Author's reply
por: Dubashi, Biswajit, et al.
Publicado: (2012)

Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.
por: de Jong, R. S., et al.
Publicado: (1997)

Ethics of genomic research
por: Mathaiyan, Jayanthi, et al.
Publicado: (2013)

RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer
por: Morgensztern, Daniel, et al.
Publicado: (2019)

Tumor lysis syndrome in multiple myeloma treated with bortezomib
por: Dhanraj, K. M., et al.
Publicado: (2014)

A phase 2, open-label, multi-center study of amuvatinib in combination with platinum etoposide chemotherapy in platinum-refractory small cell lung cancer patients
por: Byers, Lauren Averett, et al.
Publicado: (2017)

A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada
por: Elegbede, Anifat A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_39gumheh71ijk0cpee45250p77